Adult-Onset Still’s Disease: New Clinical Guidelines Released
- * Adult-Onset Still's Disease (AOSD) is gaining recognition as a distinct disease: Previously often misdiagnosed, AOSD is now understood to require specific management strategies.
- In essence, this news release announces EULAR's efforts to standardize the assessment and management of AOSD, a relatively rare and often overlooked inflammatory condition.
Here’s a summary of the provided text:
Key Points:
* Adult-Onset Still’s Disease (AOSD) is gaining recognition as a distinct disease: Previously often misdiagnosed, AOSD is now understood to require specific management strategies.
* EULAR is developing criteria for assessing disease activity: The European Alliance of Associations for Rheumatology (EULAR) has released “points to consider” to aid in creating a reliable tool for evaluating how active the disease is in patients.
* Goal is improved clinical management: The aim is to provide clinicians with a practical tool to better manage AOSD and improve patient outcomes.
* Published Research: The work is detailed in an article published in EULAR Rheumatology Open (DOI: 10.1016/j.ero.2025.11.015).
* Publication Date: December 11, 2025.
In essence, this news release announces EULAR’s efforts to standardize the assessment and management of AOSD, a relatively rare and often overlooked inflammatory condition.